Aisiku Imoigele 4

What Happened Aisiku Imoigele, CEO of VSEE Health, received four equity award issuances (code A) on March 23, 2026 under the company's 2024 Incentive Plan as quarterly awards due under his December 10, 2025 Employment Agreement. The grants total 288,410 shares comprised of:

• 128,342 shares at $0.37/share — $47,487
• 78,689 shares at $0.61/share — $48,000
• 41,379 shares at $1.16/share — $48,000
• 40,000 shares at $1.20/share — $48,000 Total value reported for the issuances is approximately $191,487. These are compensation awards (not open-market purchases or option exercises).

Key Details

• Transaction date: 2026-03-23; Form 4 filed: 2026-03-24 (filed the next day; Form 4s are generally due within two business days).
• Prices and values: see itemized list above (per-share prices determined by closing prices on quarter-end dates).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: each grant corresponds to a quarterly equity award for a specific quarter in 2025 (F1 = quarter ended 12/31/2025; F2 = 9/30/2025; F3 = 6/30/2025; F4 = 3/31/2025); number of shares was based on the common stock closing price on each respective quarter-end date.
• Transaction code: A = Award/Grant (equity compensation).

Context These awards are part of contractual compensation under Imoigele’s Employment Agreement and were issued under the company’s Incentive Plan. Such grants reflect compensation, not an open-market purchase or sale; they are common for executives and don’t necessarily signal personal trading intent.